Solesence Inc. (SLSN): Price to Sales

Corporate company logo of Solesence Inc. (SLSN)

Market protection via Kleair patents and FDA regulations creates a significant barrier to entry for competitors. Solesence Inc (SLSN) ensures high margins and stable cash flow by supplying unique mineral components to B2B partners. Pharmaceutical-grade specialized transportation guarantees the reliability of supply chains. P/S volatility reflects the price action's reaction to these factors, while the 1.20 metric determines the status of the business valuation parameter relative to revenue.

Solesence Inc - SLSN P/S Multiple (period 04/09/2025 - 11/13/2026)

Analytical breakdowns for Solesence Inc (SLSN)

- price and consensus price forecast:
Market Chart solesence.com|SLSN - Price Target Chart
- stock exchange capitalization data:
Market Value Solesence Inc.|SLSN - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Solesence Inc|SLSN - Book Capitalization|Market-to-Book Ratio solesence.com|SLSN - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Solesence Inc|SLSN - Long-Term Debt to Capital|Current Liabilities to Capital solesence.com|SLSN - Company Debts|Debt to Book Value Ratio Solesence Inc.|SLSN - Company Long-Term Debts|Company Current Liabilities Solesence Inc|Immediate Liquidity solesence.com
- financial results and valuation multiples details:
SLSN - Net Income|Expected Net Income Solesence Inc|SLSN - P/E Multiple|Market Cap to Projected Earnings solesence.com|SLSN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Solesence Inc.|SLSN - Operating profit EBITDA|Net earnings per share for the last 12 months Solesence Inc|SLSN - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months solesence.com|SLSN - Earnings per share growth in current year|Net earnings per share growth forecast for next year Solesence Inc
- issuer revenue and sales details:
SLSN - Company Revenue|Company Future Sales solesence.com|SLSN - Price-to-Revenue Ratio|Market Cap to Projected Revenue Solesence Inc.
Fundamental company analysis:Solesence Beauty (SLSN)
Core merchandise of Solesence Inc.

The P/S ratio reflects the market value of a business relative to its total sales, allowing investors to separate speculative asset overvaluation from actual cash flows. Analyzing the price-to-sales ratio helps identify a discounted entry point, which is particularly relevant for Solesence Inc (SLSN), whose innovative mineral skin protection formulas provide expansion potential within the premium cosmetics market.

Competing companies

Price-to-Revenue Coefficient krystalbio.com|Price-to-Revenue Ratio Apogee Therapeutics, Inc. APGE|Arcutis (ARQT) - Price to Sales|VCEL - Price-to-Revenue Ratio|ORKA: Price-to-Revenue Ratio|SMTI: P/S Multiple|Price to Sales DBV Technologies (DBVT)|Price-to-Revenue Ratio Journey Medical Corp|Forte Biosciences Inc. (FBRX) - Price-to-Revenue Coefficient|P/S Multiple EMPG|SLGL - Price to Sales|Price-to-Revenue Ratio AXIL Brands AXIL|MDCX: Market Cap to Revenue Ratio|Verrica - P/S Multiple|Hoth Therapeutics, Inc. (HOTH) - Market Cap to Revenue|BFRI: P/S Multiple|Price to Sales VYNE Therapeutics Inc. (VYNE)|Market Cap to Revenue SNOA|QNRX: Market Capitalization-to-Revenue Ratio|P/S Multiple AZTR|Price-to-Revenue Coefficient Dermata Therapeutics Inc|Price-to-Revenue Ratio Elevai Skincare ELAB|RVNC: Market Cap to Revenue Ratio